GlobeNewswire

Kerry Wentworth, Chief Regulatory Officer at Flexion Therapeutics, appointed to Massachusetts Biotechnology Council Board

Kerry Wentworth, Chief Regulatory Officer at Flexion Therapeutics, appointed to Massachusetts Biotechnology Council Board

Flexion Therapeutics today announced that Kerry Wentworth, Chief Regulatory Officer, has been appointed to the Massachusetts Biotechnology Council Board of Directors.
Flexion Therapeutics, Inc.
Format

JPEG

Source

Flexion Therapeutics, Inc.

Downloads